UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations

Clinical cancer research, 2019-10, Vol.25 (19), p.5832-5842

2019

Volltextzugriff (PDF)

Management of medullary thyroid carcinoma and MEN2 syndromes in childhood

Nature reviews. Endocrinology, 2011-10, Vol.7 (10), p.596-607

2011

Volltextzugriff (PDF)

Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion BRCA Mutations among Patients with Advanced Solid Tumors

Clinical cancer research, 2020-06, Vol.26 (11), p.2546-2555

2020

Volltextzugriff (PDF)

Current and Future Treatments for Malignant Pheochromocytoma and Sympathetic Paraganglioma

Current oncology reports, 2013-08, Vol.15 (4), p.356-371

2013

Volltextzugriff (PDF)

Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

Clinical cancer research, 2024-07, Vol.30 (14), p.2964-2973

2024

Volltextzugriff (PDF)

Hereditary breast cancer syndromes and genetic testing

Journal of surgical oncology, 2015-01, Vol.111 (1), p.66-80

2015

Volltextzugriff (PDF)

ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C)

BMC cancer, 2023-03, Vol.23 (1), p.257-257, Article 257

2023

Volltextzugriff (PDF)

Long-Term Outcomes of Surgical Treatment for Hereditary Pheochromocytoma

Journal of the American College of Surgeons, 2013-02, Vol.216 (2), p.280-289

2013

Volltextzugriff (PDF)

The Characterization of Pheochromocytoma and Its Impact on Overall Survival in Multiple Endocrine Neoplasia Type 2

The journal of clinical endocrinology and metabolism, 2013-11, Vol.98 (11), p.E1813-E1819

2013

Volltextzugriff (PDF)

Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases

Genes chromosomes & cancer, 2014-02, Vol.53 (2), p.177-182

2014

Volltextzugriff (PDF)

Mutation profile differences in younger and older patients with advanced breast cancer using circulating tumor DNA (ctDNA)

Breast cancer research and treatment, 2021-02, Vol.185 (3), p.639-646

2021

Volltextzugriff (PDF)

Use of the Tyrosine Kinase Inhibitor Sunitinib in a Patient with von Hippel-Lindau Disease: Targeting Angiogenic Factors in Pheochromocytoma and Other von Hippel-Lindau Disease-Related Tumors

The journal of clinical endocrinology and metabolism, 2009-02, Vol.94 (2), p.386-391

2009

Volltextzugriff (PDF)

Duration of Targeted Therapy in Patients With Advanced Non–small-cell Lung Cancer Identified by Circulating Tumor DNA Analysis

Clinical lung cancer, 2020-11, Vol.21 (6), p.545-552.e1

2020

Volltextzugriff (PDF)

Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation

Thyroid (New York, N.Y.), 2011-02, Vol.21 (2), p.189-192

2011

Volltextzugriff (PDF)

Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma

Annals of surgical oncology, 2018-05, Vol.25 (5), p.1395-1402

2018

Volltextzugriff (PDF)

Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A?

Surgery, 2010-12, Vol.148 (6), p.1302-1310

2010

Volltextzugriff (PDF)

Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations

Thyroid (New York, N.Y.), 2014-07, Vol.24 (7), p.1096-1106

2014

Volltextzugriff (PDF)

Preliminary whole-exome sequencing reveals mutations that imply common tumorigenicity pathways in multiple endocrine neoplasia type 1 patients

Surgery, 2014-12, Vol.156 (6), p.1351-1358

2014

Volltextzugriff (PDF)

Multiple Endocrine Neoplasia Syndromes

The Surgical clinics of North America, 2008-08, Vol.88 (4), p.863-895

2008

Volltextzugriff (PDF)

Ultrasonography Should Not Guide the Timing of Thyroidectomy in Pediatric Patients Diagnosed with Multiple Endocrine Neoplasia Syndrome 2A through Genetic Screening

Annals of surgical oncology, 2013-01, Vol.20 (1), p.53-59

2013

Volltextzugriff (PDF)

Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes

Familial cancer, 2014-06, Vol.13 (2), p.291-299

2014

Volltextzugriff (PDF)

Achieving eugastrinemia in MEN1 patients: Both duodenal inspection and formal lymph node dissection are important

Surgery, 2011-12, Vol.150 (6), p.1143-1152

2011

Volltextzugriff (PDF)

Identification of Actionable Fusions as an Anti-EGFR Resistance Mechanism Using a Circulating Tumor DNA Assay

JCO precision oncology, 2019 (3), p.1-15

2019

Volltextzugriff (PDF)

Failure to Recognize Multiple Endocrine Neoplasia 2B: More Common Than We Think?

Annals of surgical oncology, 2008, Vol.15 (1), p.293-301

2008

Volltextzugriff (PDF)

Medullary Thyroid Carcinoma Associated with Germline RET K666N Mutation

Thyroid (New York, N.Y.), 2016-12, Vol.26 (12), p.1744-1751

2016

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(65)

Publikationsform

Sprache

Englisch
(85)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations

Management of medullary thyroid carcinoma and MEN2 syndromes in childhood

Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion BRCA Mutations among Patients with Advanced Solid Tumors

Current and Future Treatments for Malignant Pheochromocytoma and Sympathetic Paraganglioma

Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

Hereditary breast cancer syndromes and genetic testing

ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C)

Long-Term Outcomes of Surgical Treatment for Hereditary Pheochromocytoma

The Characterization of Pheochromocytoma and Its Impact on Overall Survival in Multiple Endocrine Neoplasia Type 2

Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases

Mutation profile differences in younger and older patients with advanced breast cancer using circulating tumor DNA (ctDNA)

Use of the Tyrosine Kinase Inhibitor Sunitinib in a Patient with von Hippel-Lindau Disease: Targeting Angiogenic Factors in Pheochromocytoma and Other von Hippel-Lindau Disease-Related Tumors

Duration of Targeted Therapy in Patients With Advanced Non–small-cell Lung Cancer Identified by Circulating Tumor DNA Analysis

Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation

Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma

Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A?

Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations

Preliminary whole-exome sequencing reveals mutations that imply common tumorigenicity pathways in multiple endocrine neoplasia type 1 patients

Multiple Endocrine Neoplasia Syndromes

Ultrasonography Should Not Guide the Timing of Thyroidectomy in Pediatric Patients Diagnosed with Multiple Endocrine Neoplasia Syndrome 2A through Genetic Screening

Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes

Achieving eugastrinemia in MEN1 patients: Both duodenal inspection and formal lymph node dissection are important

Identification of Actionable Fusions as an Anti-EGFR Resistance Mechanism Using a Circulating Tumor DNA Assay

Failure to Recognize Multiple Endocrine Neoplasia 2B: More Common Than We Think?

Medullary Thyroid Carcinoma Associated with Germline RET K666N Mutation

Suchergebnisse filtern